Scaling telehealth rehabilitation may reduce travel and facility constraints but must address device/internet availability, ...
TuHURA Biosciences, Inc. ("TuHURA" or the "Company"), a Phase 3 immuno-oncology company developing novel therapeutics to overcome resistance to cancer immunotherapy, today announced that it has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results